RU2167150C2 - Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity - Google Patents
Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity Download PDFInfo
- Publication number
- RU2167150C2 RU2167150C2 RU98105448/04A RU98105448A RU2167150C2 RU 2167150 C2 RU2167150 C2 RU 2167150C2 RU 98105448/04 A RU98105448/04 A RU 98105448/04A RU 98105448 A RU98105448 A RU 98105448A RU 2167150 C2 RU2167150 C2 RU 2167150C2
- Authority
- RU
- Russia
- Prior art keywords
- polyfluoroalkyl
- arylcarbamates
- antibacterial activity
- nhcoochr
- showing antibacterial
- Prior art date
Links
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Изобретение относится к применению фторсодержащих производных карбаминовой кислоты, а именно полифторалкил-N-арилкарбаматов общей формулы
где R и R' = H, о-, м или п-алкил C1-C3, CF3, CH3S, Cl, NO2, NHCOOCHR''R''';
R'' = H, CF3;
R''' = CF3, (CF2)nH, где n = 2-6, или CF2NO2 за исключением 2.2-дифтор-2-нитроэтил-N-фенилкарбамата, 2.2.2-трифторэтил-N-п-нитрофенилкарбамата,
обладающие антимикробной активностью.The invention relates to the use of fluorine derivatives of carbamic acid, namely polyfluoroalkyl-N-arylcarbamates of the general formula
where R and R '= H, o-, m or p-alkyl C 1 -C 3 , CF 3 , CH 3 S, Cl, NO 2 , NHCOOCHR "R"'';
R "= H, CF 3 ;
R '''= CF 3 , (CF 2 ) n H, where n = 2-6, or CF 2 NO 2 with the exception of 2.2-difluoro-2-nitroethyl-N-phenylcarbamate, 2.2.2-trifluoroethyl-N-p nitrophenyl carbamate,
possessing antimicrobial activity.
Описано использование бис-(карбаматов) из высших (≥ C10) полифторалканолов и толуилендиизоцианата, используемых для придания тканям водо- и маслоотталкивающих свойств [Пат. США N 3171861, опубл. 1965]. Последние соединения выходят за пределы формулы (1) - более высшие спирты. Сведения об антимикробной активности полифторалкил-N-арилкарбаматов в литературе отсутствуют.The use of bis- (carbamates) from higher (≥ C 10 ) polyfluoroalkanols and toluene diisocyanate used to impart water- and oil-repellent properties to tissues is described [Pat. United States N 3171861, publ. 1965]. The latter compounds go beyond the formula (1) - higher alcohols. Information on the antimicrobial activity of polyfluoroalkyl-N-arylcarbamates is not available in the literature.
Задачей предлагаемого изобретения является создание принципиально новых веществ с высокой антимикробной активностью широкого спектра действия, отличающихся исключительно низкой токсичностью и совершенно не опасных для человека. The objective of the invention is to create a fundamentally new substances with high antimicrobial activity of a wide spectrum of action, characterized by extremely low toxicity and completely harmless to humans.
Сущность предлагаемого изобретения достигается сочетанием в предлагаемых соединениях ароматического заместителя у атома азота и ≥ 2 атомов фтора в β-положении алкильного у остатка, что ведет к проявлению ими антимикробных свойств. Замена N-арильного заместителя на бензил или пиперидил (соединения 25 и 26, табл. N 1) резко снижает их антимикробную активность. Более удаленное расположение атомов фтора (по сравнению с β-положением) также снижает бактерицидность (см. соединение 27 табл. N 1). The essence of the invention is achieved by combining in the proposed compounds an aromatic substituent at the nitrogen atom and ≥ 2 fluorine atoms in the β-position of the alkyl at the residue, which leads to their manifestation of antimicrobial properties. Replacing the N-aryl substituent with benzyl or piperidyl (
Методика исследования антибактериальной активности. The methodology for the study of antibacterial activity.
Антимикробную активность синтезированных соединений исследовали в плотной питательной среде методом "диффузии в агаре" или луночным методом. The antimicrobial activity of the synthesized compounds was studied in a dense nutrient medium by the method of "diffusion in agar" or by the hole method.
Поверхность чашки Петри с твердым питательным агаром засевают сплошным "газоном" взвеси суточной культуры по бактериальному стандарту. Чашку подсушивают 40 мин в термостате, затем в середину чашки в лунку вносят по 3 капли раствора исследуемого вещества (10%, 1% или 0.1%) и чашку термостатируют при 37oC 24 ч.The surface of the Petri dish with solid nutrient agar is seeded with a continuous "lawn" suspension of daily culture according to the bacterial standard. The cup is dried for 40 minutes in a thermostat, then 3 drops of a solution of the test substance (10%, 1% or 0.1%) are added to the well in the middle of the cup and the cup is thermostated at 37 ° C for 24 hours.
Результаты исследования оценивают визуально, измеряя зоны задержки роста микробов после инкубации. The results of the study are evaluated visually by measuring areas of growth inhibition of microbes after incubation.
Для испытаний использованы грамположительные бактерии - стафилококк белый, стафилококк золотистый (906), палочка антракоида (1312) и грамотрицательная кишечная палочка (25922). Результаты приведены в табл. N 1. Gram-positive bacteria were used for the tests: white staphylococcus, Staphylococcus aureus golden (906), anthracoid bacillus (1312) and gram-negative Escherichia coli (25922). The results are shown in table.
Некоторые из синтезированных соединений испытаны на патогенных грибах - Candida albicaus ATCC 885-653 - одноклеточные дрожжеподобные грибы, и показали активность средней силы. Some of the synthesized compounds were tested on pathogenic fungi — Candida albicaus ATCC 885-653 — unicellular yeast-like fungi, and showed moderate potency.
Как следует из данных табл. N 1 заявляемые полифторалкил-N-арилкарбаматы по своей антимикробной активности конкурентноспособны с известными бактерицидами как фенол, монохлорамин (ДТ-1) и даже K-соль пенициллина. As follows from the data table.
Результаты биологических исследований, приведенные в табл. N 1, свидетельствуют, что высокая антимикробная активность и низкая токсичность заявляемых веществ делает возможным их использование в качестве химиотерапевтических и антисептических средств для медицинской практики, в частности для профилактики бактериальных инфекций и грибковых поражений на поверхности. The results of biological studies are given in table.
Пример. К 0.9 г фенилизоцианата добавили 2.5 г 1,1,7-тригидрододекафторгептанола-1 и 3 капли триэтиламина, после окончания экзотермической реакции смесь нагревают 1 ч на кипящей водяной бане и кристаллизуют из гексана. Выход 2.6 г (76.5%) 1,1,7-тригидрододекафторгептанил-N-фенилкарбамата, т.пл. 47-48oC. Аналогично получены другие соединения, представленные в табл. N 2.Example. 2.5 g of 1,1,7-trihydrododecafluoroheptanol-1 and 3 drops of triethylamine were added to 0.9 g of phenylisocyanate; after the end of the exothermic reaction, the mixture was heated for 1 h in a boiling water bath and crystallized from hexane. Yield 2.6 g (76.5%) of 1,1,7-trihydrododecafluoroheptanyl-N-phenylcarbamate, mp. 47-48 o C. Similarly, other compounds are presented, are presented in table.
Свойства полученных соединений и их выход приведены в табл. N 2. The properties of the obtained compounds and their yield are given in table.
Claims (1)
где R, R'= H, o-, м-, или п-алкил C1-C3, CF3, CH3S, Cl, NO, NHCOOCHR''R''';
R''=H,CF;
R'''= CF3, (CF2)nH, где n = 2 - 6, или CF2NO2, за исключением 2,2-дифтор-2-нитроэтил-N-фенилкарбамата, 2,2,2-трифторэтил-N-n-нитрофенилкарбамата,
обладающие антимикробной активностью.Polyfluoroalkyl-N-arylcarbamates of Formula I
where R, R '= H, o-, m-, or p-alkyl C 1 -C 3 , CF 3 , CH 3 S, Cl, NO, NHCOOCHR "R"'';
R "= H, CF;
R '''= CF 3 , (CF 2 ) n H, where n = 2-6, or CF 2 NO 2 , with the exception of 2,2-difluoro-2-nitroethyl-N-phenylcarbamate, 2,2,2- trifluoroethyl-Nn-nitrophenylcarbamate,
possessing antimicrobial activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU98105448/04A RU2167150C2 (en) | 1998-03-25 | 1998-03-25 | Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU98105448/04A RU2167150C2 (en) | 1998-03-25 | 1998-03-25 | Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98105448A RU98105448A (en) | 1999-12-20 |
RU2167150C2 true RU2167150C2 (en) | 2001-05-20 |
Family
ID=20203847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98105448/04A RU2167150C2 (en) | 1998-03-25 | 1998-03-25 | Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2167150C2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2515896C2 (en) * | 2008-08-08 | 2014-05-20 | Байер Матириальсайенс Аг | Urethane acrylates based on phenylisocyanate, method for production thereof, use thereof to produce holographic media or photopolymer films, method of coating holographic media and photopolymer films and moulded components based on said urethane acrylates |
EP2800565A1 (en) * | 2012-01-06 | 2014-11-12 | Abide Therapeutics, Inc. | Carbamate compounds and of making and using same |
US9771341B2 (en) | 2015-03-18 | 2017-09-26 | Abide Therapeutics, Inc. | Piperazine carbamates and methods of making and using same |
US9981930B1 (en) | 2016-11-16 | 2018-05-29 | Abide Therapeutics, Inc. | MAGL inhibitors |
US10093635B2 (en) | 2016-11-16 | 2018-10-09 | Abide Therapeutics, Inc. | MAGL inhibitors |
US10450302B2 (en) | 2015-05-11 | 2019-10-22 | Lundbeck La Jolla Research Center, Inc. | Methods of treating inflammation or neuropathic pain |
US10463753B2 (en) | 2016-02-19 | 2019-11-05 | Lundbeck La Jolla Research Center, Inc. | Radiolabeled monoacylglycerol lipase occupancy probe |
US10570106B2 (en) | 2018-05-15 | 2020-02-25 | Lundbeck La Jolla Research Center, Inc. | MAGL inhibitors |
US10899737B2 (en) | 2016-09-19 | 2021-01-26 | Lundbeck La Jolla Research Center, Inc. | Piperazine carbamates and methods of making and using same |
US11702393B2 (en) | 2020-04-21 | 2023-07-18 | H. Lundbeck A/S | Synthesis of a monoacylglycerol lipase inhibitor |
US12018004B2 (en) | 2022-11-08 | 2024-06-25 | H. Lundbeck A/S | Carbamate compounds and methods of making and using same |
-
1998
- 1998-03-25 RU RU98105448/04A patent/RU2167150C2/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
HEGARTY F. ET AL. Elimination-Addition Mechanism for the Hydrolysis of Carbamates. JOURNAL OF THE CHEMICAL SOCIETY, Perkin Trans. II.-1973, № 12, p.1727. * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2515896C2 (en) * | 2008-08-08 | 2014-05-20 | Байер Матириальсайенс Аг | Urethane acrylates based on phenylisocyanate, method for production thereof, use thereof to produce holographic media or photopolymer films, method of coating holographic media and photopolymer films and moulded components based on said urethane acrylates |
US9487495B2 (en) | 2012-01-06 | 2016-11-08 | The Scripts Research Institute | Carbamate compounds and of making and using same |
CN104159581A (en) * | 2012-01-06 | 2014-11-19 | 阿比德治疗公司 | Carbamate compounds and of making and using same |
EP2800565A4 (en) * | 2012-01-06 | 2015-04-29 | Abide Therapeutics Inc | Carbamate compounds and of making and using same |
US9133148B2 (en) | 2012-01-06 | 2015-09-15 | The Scripps Research Institute | Carbamate compounds and of making and using same |
AU2013207252B2 (en) * | 2012-01-06 | 2016-06-09 | H.Lundbeck A/S | Carbamate compounds and pharmaceutical compositions thereof |
US11021453B2 (en) | 2012-01-06 | 2021-06-01 | Lundbeck La Jolla Research Center, Inc. | Carbamate compounds and methods of making and using same |
US9957242B2 (en) | 2012-01-06 | 2018-05-01 | The Scripps Research Institute | Carbamate compounds and methods of making and using same |
CN107982266A (en) * | 2012-01-06 | 2018-05-04 | 阿比德治疗公司 | Carbamate compounds and its preparation and application |
US11530189B2 (en) | 2012-01-06 | 2022-12-20 | H. Lundbecka/S | Carbamate compounds and methods of making and using same |
EP2800565A1 (en) * | 2012-01-06 | 2014-11-12 | Abide Therapeutics, Inc. | Carbamate compounds and of making and using same |
US9771341B2 (en) | 2015-03-18 | 2017-09-26 | Abide Therapeutics, Inc. | Piperazine carbamates and methods of making and using same |
US9994537B2 (en) | 2015-03-18 | 2018-06-12 | Abide Therapeutics, Inc. | Piperazine carbamates and methods of making and using same |
US11034674B2 (en) | 2015-05-11 | 2021-06-15 | H. Lundbeck A/S | Methods of treating inflammation or neuropathic pain |
US10450302B2 (en) | 2015-05-11 | 2019-10-22 | Lundbeck La Jolla Research Center, Inc. | Methods of treating inflammation or neuropathic pain |
US10463753B2 (en) | 2016-02-19 | 2019-11-05 | Lundbeck La Jolla Research Center, Inc. | Radiolabeled monoacylglycerol lipase occupancy probe |
US10899737B2 (en) | 2016-09-19 | 2021-01-26 | Lundbeck La Jolla Research Center, Inc. | Piperazine carbamates and methods of making and using same |
US10093635B2 (en) | 2016-11-16 | 2018-10-09 | Abide Therapeutics, Inc. | MAGL inhibitors |
US9981930B1 (en) | 2016-11-16 | 2018-05-29 | Abide Therapeutics, Inc. | MAGL inhibitors |
US10570106B2 (en) | 2018-05-15 | 2020-02-25 | Lundbeck La Jolla Research Center, Inc. | MAGL inhibitors |
US11214557B2 (en) | 2018-05-15 | 2022-01-04 | H. Lundbeck A/S | MAGL inhibitors |
US11332453B2 (en) | 2018-05-15 | 2022-05-17 | H. Lundbeck A/S | MAGL inhibitors |
US11702393B2 (en) | 2020-04-21 | 2023-07-18 | H. Lundbeck A/S | Synthesis of a monoacylglycerol lipase inhibitor |
US12018004B2 (en) | 2022-11-08 | 2024-06-25 | H. Lundbeck A/S | Carbamate compounds and methods of making and using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3204962B2 (en) | Quaternary ammonium polymer trihalides and uses thereof | |
RU2167150C2 (en) | Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity | |
US20030032765A1 (en) | Antimicrobial polymer | |
BRPI0617446A2 (en) | amphoteric compound, use thereof, methods for the control of phytopathogenic fungi and bacteria and / or the mitigation of abiotic and biatic stress in agricultural crops, and for the stimulation of natural defense systems of abiotic and biotic stress plants and for induction of resistance in the crops themselves, fungicidal composition, and use of the composition | |
HU227487B1 (en) | Fungicidal compositions based on (n-phenylacetyl-n-2,6-xylyl)methyl alaninate (benalaxyl), use thereof | |
RU2039036C1 (en) | Biocidal composition and method of inhibiting growth of microorganisms in media | |
WO2019022637A1 (en) | Antiseptic medicinal agent | |
US5420350A (en) | Bis-biguanide compound useful as a disinfectant | |
GB2058071A (en) | N-aryl-N-acyl-3-amino-oxazolidin- 2-one fungicides | |
US4472404A (en) | 8-Quinolinyl carbamates and their use as urinary tract antimicrobials | |
EP0160322B1 (en) | Iodonium ylide compositions and method for antimicrobial use | |
US4477461A (en) | N-Aryl-N-acyl-3-amino-1,3-oxazolidine-2-thiones having fungicidal activity | |
CA2166588A1 (en) | Storage stable biocide composition and process for making the same | |
US3711271A (en) | Method for controlling algae | |
US3936466A (en) | 3-Chloro-tetrahydro-1,3-oxazines or oxazolidines spiro substituted | |
RU2773080C1 (en) | Trimeric quaternary pyridinium salts with biocidal action | |
RU1781211C (en) | N,n'-bis (vinylhydroxyethyl) thiuram-disulfide exhibiting fungicidal and bactericidal | |
US3991195A (en) | Method of controlling bacteria | |
RU2365596C1 (en) | Copolymers of diallylaminophosphonium salts with sulphur dioxide demonstrating anti-microbial activity | |
RU2287273C1 (en) | Using n-substituted 3-cyano-4,6-dimethyl-5-chloropyridyl-2-sulfonylamides as antidotes of herbicide 2,4-dichlorophenoxyacetic acid in sunflower | |
RU2050352C1 (en) | Diethyl aminomethyl urea as antimicrobic additive for cutting liquids | |
US4238503A (en) | Anilide urea biocides | |
US3946016A (en) | Fungicidal 8-quinolyl carbanilates | |
US3909231A (en) | Cyano substituted malanilate biocides | |
RU2163236C2 (en) | 1-(21-hydroxyphenyl)-2-methylpyrrole showing antibacterial activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20060326 |